Belimumab (GSK1550188) clinical trials

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

This study looks at a medicine called Belimumab for people with Systemic Lupus Erythematosus (SLE), also known as lupus. It aims to see how well and how safely it works over three years in people who have had lupus for a short time and whose current treatment isn't fully controlling their symptoms.